Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Evogene Ltd. Regulatory Filings 2023

Jul 17, 2023

6785_rns_2023-07-17_0317fa4a-b5b5-47f3-95d5-d0d18332d50c.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

July 17, 2023 431096.docx

==> picture [111 x 87] intentionally omitted <==

To: TASE Members Dear Sir/Madam,

Re: EVOGENE LTD (ISIN no. IL0011050551)

Further to the company's request, trading in its shares was halted until the completion of pricing in U.S.

Sincerely

(-)

Listing companies compliance unit

==> picture [453 x 48] intentionally omitted <==